PMID- 38239986 OWN - NLM STAT- MEDLINE DCOM- 20240122 LR - 20240304 IS - 1664-2392 (Print) IS - 1664-2392 (Electronic) IS - 1664-2392 (Linking) VI - 14 DP - 2023 TI - Association between neutrophil-to-lymphocyte ratio and diabetic kidney disease in type 2 diabetes mellitus patients: a cross-sectional study. PG - 1285509 LID - 10.3389/fendo.2023.1285509 [doi] LID - 1285509 AB - AIMS: This investigation examined the possibility of a relationship between neutrophil-to-lymphocyte ratio (NLR) and diabetic kidney disease (DKD) in type 2 diabetes mellitus (T2DM) patients. METHODS: Adults with T2DM who were included in the National Health and Nutrition Examination Survey (NHANES) between 1999 and 2020 were the subjects of the current cross-sectional investigation. Low estimated glomerular filtration rate (eGFR) (< 60 mL/min/1.73 m(2)) or albuminuria (urinary albumin-to-creatinine ratio (ACR) >/= 30 mg/g) in T2DM patients were the diagnostic criteria for DKD. Weighted multivariable logistic regression models and generalized additive models were used to investigate the independent relationships between NLR levels with DKD, albuminuria, and low-eGFR. Additionally, we examined the relationships between DKD, albuminuria, and low-eGFR with other inflammatory markers, such as the aggregate index of systemic inflammation (AISI), systemic immune-inflammation index (SII), system inflammation response index (SIRI), and platelet-to-lymphocyte ratio (PLR) and monocyte-to-lymphocyte ratio (MLR). Their diagnostic capabilities were evaluated and contrasted using receiver operating characteristic (ROC) curves. RESULTS: 44.65% of the 7,153 participants who were recruited for this study were males. DKD, albuminuria, and low-eGFR were prevalent in 31.76%, 23.08%, and 14.55% of cases, respectively. Positive correlations were seen between the NLR with the prevalences of DKD, albuminuria, and low-eGFR. Subgroup analysis and interaction tests revealed that the associations of NLR with DKD, albuminuria, and low-eGFR were not significantly different across populations. In addition, MLR, SII and SIRI showed positive associations with the prevalence of DKD. ROC analysis discovered that when compared to other inflammatory markers (MLR, PLR, SII, SIRI, and AISI), NLR may demonstrate more discriminatory power and accuracy in assessing the risk of DKD, albuminuria, and low-eGFR. CONCLUSION: Compared to other inflammatory markers (MLR, PLR, SII, SIRI, and AISI), NLR may serve as the more effective potential inflammatory marker for identifying the risk of DKD, albuminuria, and low-eGFR in US T2DM patients. T2DM patients with elevated levels of NLR, MLR, SII, and SIRI should be closely monitored for their potential risk to renal function. CI - Copyright (c) 2024 Li, Wang, Liu, Zhou and Xu. FAU - Li, Xiaowan AU - Li X AD - Department of Critical Care Medicine, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, China. FAU - Wang, Lanyu AU - Wang L AD - Department of Urology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, China. FAU - Liu, Min AU - Liu M AD - Department of Critical Care Medicine, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, China. FAU - Zhou, Hongyi AU - Zhou H AD - Department of Urology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, China. FAU - Xu, Hongyang AU - Xu H AD - Department of Critical Care Medicine, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, China. LA - eng PT - Journal Article DEP - 20240104 PL - Switzerland TA - Front Endocrinol (Lausanne) JT - Frontiers in endocrinology JID - 101555782 SB - IM MH - Male MH - Adult MH - Humans MH - Female MH - *Diabetic Nephropathies/etiology/complications MH - *Diabetes Mellitus, Type 2/complications MH - Cross-Sectional Studies MH - Nutrition Surveys MH - Neutrophils MH - Albuminuria/etiology MH - Lymphocytes MH - Inflammation/complications PMC - PMC10795842 OTO - NOTNLM OT - NHANES OT - diabetic kidney disease OT - neutrophil-to-lymphocyte ratio OT - population-based study OT - type 2 diabetes mellitus COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2024/01/19 06:42 MHDA- 2024/01/22 06:42 PMCR- 2023/01/01 CRDT- 2024/01/19 03:49 PHST- 2023/08/30 00:00 [received] PHST- 2023/11/30 00:00 [accepted] PHST- 2024/01/22 06:42 [medline] PHST- 2024/01/19 06:42 [pubmed] PHST- 2024/01/19 03:49 [entrez] PHST- 2023/01/01 00:00 [pmc-release] AID - 10.3389/fendo.2023.1285509 [doi] PST - epublish SO - Front Endocrinol (Lausanne). 2024 Jan 4;14:1285509. doi: 10.3389/fendo.2023.1285509. eCollection 2023.